Top in GI: Celiac disease management; nocturnal gastroesophageal reflux
Click Here to Manage Email Alerts
New therapies for celiac disease are on the horizon, according to experts. In a recent cover story, Healio explored the present and future state of celiac disease management and pearls for treating this special subset of patients.
It was the top story in gastroenterology last week.
Another top story was about a new study that identified a link between left lateral sleep position and shorter esophageal acid exposure compared with other sleep positions in patients with nocturnal gastroesophageal reflux.
Read these and more top stories in gastroenterology below:
Management of patients with celiac disease is ‘a marathon not a sprint’
Celiac disease is a chronic, autoimmune digestive disease that damages small intestinal villi and interferes with absorption of nutrients. While much is known about the development of the disease and its effect on the body, questions remain about screening, diagnosis and patient care now and in the years ahead. Read more.
Left lateral sleep position may alleviate nocturnal esophageal acid exposure, symptoms
Among patients who experience nocturnal gastroesophageal reflux, the left lateral decubitus sleep position correlated with significantly shorter esophageal acid exposure time and faster esophageal acid clearance, according to research. Read more.
Smart Medical G-Eye colonoscope receives additional FDA clearance
Smart Medical Systems Ltd. announced the FDA has approved its G-Eye colonoscope, based on Olympus 510(k)-cleared PCF colonoscope series. Read more.
Anti-TNF, surgical closure induces long-term healing in Crohn’s fistulas
Short-term anti-tumor necrosis factor treatment combined with surgical closure induced long-term MRI healing in patients with Crohn’s perianal fistulas more frequently than anti-TNF therapy alone, according to research. Read more.
Researchers report high prevalence of fatigue in IBD patients
A systematic review and meta-analysis revealed a high prevalence of fatigue among patients with inflammatory bowel disease, according to research published in Clinical Gastroenterology and Hepatology. Read more.